Medical Device Network on MSN
Synchrony Medical bolsters US COPD treatment commercialisation with $5m funding round
Synchrony Medical's LibAirty system for addressing mucus obstruction in COPD patients gained FDA clearance in July 2025.
Add Yahoo as a preferred source to see more of our stories on Google. We’ve all felt winded when taking the stairs or dealt with a cough from time to time. But if these issues linger, they could be ...
Verywell Health on MSN
How chronic obstructive pulmonary disease (COPD) is treated
Medically reviewed by Sanja Jelic, MD Key Takeaways Quitting smoking is the most important step to manage COPD.Regular exercise can help improve lung function and increase lung capacity.Breathing ...
WILMINGTON, Del.--(BUSINESS WIRE)--The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of ...
Both agents are long-acting muscarinic antagonists. The primary endpoint of the study was the change from baseline in trough FEV 1 at day 85. Findings showed no statistically significant difference ...
Asthma and COPD share similar breathing symptoms, often leading to confusion and misdiagnosis. Know key differences, risks of ...
BOSTON--(BUSINESS WIRE)--A new research study on chronic obstructive pulmonary disease (COPD) is now available in Wyomissing, Pa., for a potential treatment for reducing COPD exacerbations. The AERIFY ...
Both dupilumab and mepolizumab were originally approved for asthma but were subsequently studied in patients with COPD who continue to experience symptoms and moderate-to-severe exacerbations despite ...
A phlegmy cough and shortness of breath are possible warning signs of chronic obstructive pulmonary disease (COPD). Keeping track of your symptoms and knowing your risk factors can help you test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results